4//SEC Filing
Boucher Brent J. 4
Accession 0001567619-19-019767
CIK 0001275187other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 6:23 PM ET
Size
5.8 KB
Accession
0001567619-19-019767
Insider Transaction Report
Form 4
Boucher Brent J.
SVP and GM of Oncology
Transactions
- Award
Performance Right
2019-10-16+6,452→ 6,452 total→ Common Stock (6,452 underlying)
Footnotes (1)
- [F1]Each performance right represents a contingent right to receive one share of common stock ("Common Stock") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001766229
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 6:23 PM ET
- Size
- 5.8 KB